期刊文献+

二氢吡啶类钙通道阻滞药对人肝微粒体中氯吡格雷代谢的抑制作用 被引量:1

Inhibitory Effects of Dihydropyridines on the Metabolism of Clopidogrel in Human Liver Microsomes
原文传递
导出
摘要 目的:研究二氢吡啶类(DHPs)钙通道阻滞药硝苯地平、氨氯地平、非洛地平对人肝微粒体中氯吡格雷代谢的影响,为临床合理用药提供参考。方法:采用人肝微粒体体外代谢模型,将0.1、1、5、10、25、50、100、200μmol/L的硝苯地平、氨氯地平、非洛地平分别与氯吡格雷(20μmol/L)在人肝微粒体中进行共孵育,孵育15 min后加入5倍体积的含内标氯雷他定的冰乙腈溶液(内标终质量浓度为500 ng/ml)终止反应。沉淀蛋白后取上清液,采用超高效液相色谱-质谱(UPLC-MS)法检测氯吡格雷的浓度,以不加DHPs药物为阴性对照计算各DHPs药物作用下氯吡格雷的代谢抑制率。结果:硝苯地平、氨氯地平、非洛地平对人肝微粒体中氯吡格雷的代谢均有一定程度的抑制作用,但200μmol/L浓度时代谢抑制率仍不及50%,提示半数抑制浓度均大于200μmol/L。结论:DHPs药物能抑制人肝微粒体中氯吡格雷的代谢,但抑制作用不强。提示DHPs药物不与氯吡格雷发生相互作用,不会影响两者临床联合使用。 OBJECTIVE:To research the effects of dihydropyridines(DHPs)including nifedipine,amlodipine and felodipine on the metabolism of clopidogrel by human liver microsomes and provide reference for rational use of drug. METHODS:in vitro human liver microsome metabolism models were used. The nifedipine,amlodipine and felodipine with concentrations of 0.1,1,5,10,25,50,100 and 200 μmol/L were respectively co-incubated with clopidogrel(20 μmol/L)in human liver microsomes. After15 min co-incubation,ice acetonitrile solution of 5 times volume containing internal standard loratadine(final internal standard mass concentration was 500 ng/ml)was added to terminate the reaction. After protein precipitation,the concentration of clopidogrel was detected in the supernatant by ultra performance liquid chromatography-tandem mass(UPLC-MS)method. The metabolic inhibition rates of clopidogrel with DHPs drug were calculated on the basis of the negative control without DHPs drug. RESULTS:Nifedipine,amlodipine and felodipine had an inhibitory effect to some extent on the metabolism of clopidogrel in human liver microsomes. However,the metabolic inhibition rate was less than 50% when the drugs with the concentration of 200 μmol/L,which showed that their median inhibitory concentrations were more than 200 μmol/L. CONCLUSIONS:DHPs drug can inhibit the metabolism of clopidogrel in human liver microsomes,but the inhibition is not strong,which suggests that DHPs and clopidogrel will not interact with each other and clinical joint use of the both will not be affected.
出处 《中国药房》 CAS 北大核心 2015年第10期1349-1352,共4页 China Pharmacy
基金 常州市卫生科研项目(No.201006)
关键词 二氢吡啶类 氯吡格雷 人肝微粒体 代谢 相互作用 Dihydropyridines Clopidogrel Human liver microsomes Metabolism Interaction
  • 相关文献

参考文献11

  • 1Mega JL,Close SL,Wiviott SD,et al.Cytochrome p-450 polymorphisms and response to clopidogrel[J].N Engl J Med,2009,360(4):354.
  • 2Xia ZL,Wang ML,Zou SL,et al.Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes[J].Eur J Drug Metab Pharmacokinet,2012,37(3):211.
  • 3Zahno A,Brecht K,Bodmer M,et al.Effects of drug interactionson biotransformation and antiplatelet effect of clopidogrel in vitro[J].Br J Pharmacol,2010,161(2):393.
  • 4Kazui M,Nishiya Y,Ishizuka T,et al.Identification of the human cytochrome P450enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite[J].Drug Metab Dispos,2010,38(1):92.
  • 5Richter T,Mürdter TE,Heinkele G,et al.Inhibition of human CYP2B6 by clopidogrel and ticlopidine[J].J Pharmacol Exp Ther,2004,308(1):189.
  • 6Krippendorff BF,Lienau P,Reichel A,et al.Optimizing classification of drug-drug interaction potential for CYP450 iso-enzymes inhibition assays in early drug discovery[J].J Biomol Screen,2007,12(1):92.
  • 7徐文,孙术红,刘涛,马敏,隋忠国.金银花提取物及主要成分对药物代谢酶CYP3A4的活性抑制作用研究[J].中国执业药师,2012,9(2):3-5. 被引量:14
  • 8房晶,范国荣,李霁,李优,贺建昌,徐贵丽,李发美.苯磺酸左旋氨氯地平血药浓度的LC-MS/MS法测定及其人体内手性转化可能性考察[J].第二军医大学学报,2012,33(7):763-769. 被引量:3
  • 9余鹏,程航,刘智,郭歆,金亚超,刘星菱,程泽能.LC-MS/MS法测定人血浆中非洛地平的浓度[J].药物分析杂志,2012,32(1):35-39. 被引量:5
  • 10Olesen JB,Gislason GH,Charlot MG,et al.Calciumchannel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction[J].Journal of the American College of Cardiology,2011,57(4):409.

二级参考文献29

共引文献19

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部